| 1 minute

Synpromics Announces Collaboration with UCL to Develop Revolutionary Gene Therapy for Parkinson’s Disease

Synpromics Ltd have announced a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system (CNS), to develop a gene therapy for Parkinson’s disease.

The collaborative project will see the company develop novel gene promoters to specifically control the expression of therapeutic genes in different sub-populations of neurones. The partnership is expected to last 24 months with the work being split evenly.

To read the full article, click here.

Back to News

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News
Notice: ob_end_flush(): Failed to send buffer of zlib output compression (0) in /home/lifescsc/public_html/wp-includes/functions.php on line 5420